COMPASS Pathways plc

NasdaqGS:CMPS Stok Raporu

Piyasa değeri: US$362.6m

COMPASS Pathways Gelecekteki Büyüme

Future kriter kontrolleri 0/6

COMPASS Pathways kazanç ve gelirin sırasıyla yıllık 23.6% ve 85.2% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 29.1% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde -132.1% olacağı tahmin edilmektedir.

Anahtar bilgiler

23.6%

Kazanç büyüme oranı

29.1%

EPS büyüme oranı

Biotechs kazanç büyümesi28.0%
Gelir büyüme oranı85.2%
Gelecekteki özkaynak getirisi-132.1%
Analist kapsamı

Good

Son güncelleme01 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Nov 01

Compass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA Decision

Aug 19

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Jul 08

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

May 23

COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?

Apr 25

Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play

Feb 08

Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth

Dec 06
Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth

Booker again pushes for easier access to psychedelics for terminally ill patients

Oct 19

Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation

Aug 13
Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation

COMPASS Pathways And The Trillion Dollar Opportunity

Aug 11

COMPASS Pathways ADS Q2 2022 Earnings Preview

Aug 03

COMPASS Pathways names new CEO

Jul 19

Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy

Jun 30

We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely

Apr 28
We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely

Checking In On Compass Pathways

Mar 02

We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth

Dec 29
We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth

Compass Pathways: Psychedelics For Mental Health

Nov 23

Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy

Sep 17

COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

Sep 15
COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

Compass Pathways: Huge Growth Potential, But I'm Cautious

Jun 04

COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

May 25
COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

COMPASS Pathways raises $144M capital via equity offering

Apr 30

COMPASS Pathways launches public offering

Apr 27

We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate

Feb 08
We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate

Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront

Jan 01

Compass Pathways: Risky And Overvalued

Dec 18

What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?

Dec 18
What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?

Kazanç ve Gelir Büyüme Tahminleri

NasdaqGS:CMPS - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20269-187-183-1776
12/31/2025N/A-155-137-1357
12/31/2024N/A-157-120-1208
9/30/2024N/A-144-105-105N/A
6/30/2024N/A-139-100-100N/A
3/31/2024N/A-129-91-90N/A
12/31/2023N/A-118-97-97N/A
9/30/2023N/A-117-115-115N/A
6/30/2023N/A-102-117-117N/A
3/31/2023N/A-95-111-110N/A
12/31/2022N/A-92-106-105N/A
9/30/2022N/A-86-83-83N/A
6/30/2022N/A-84-78-77N/A
3/31/2022N/A-80-77-77N/A
12/31/2021N/A-72-68-68N/A
9/30/2021N/A-65-62-62N/A
6/30/2021N/A-66-62-62N/A
3/31/2021N/A-64-51-51N/A
12/31/2020N/A-60-42-41N/A
9/30/2020N/A-49-31-31N/A
6/30/2020N/A-38-22-22N/A
3/31/2020N/A-25-19-19N/A
12/31/2019N/A-20-18-18N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CMPS önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Kazançlar ve Piyasa: CMPS önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Yüksek Büyüme Kazançları: CMPS önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Gelir ve Pazar: CMPS gelecek yıl gelir elde edemeyeceği tahmin ediliyor.

Yüksek Büyüme Geliri: CMPS gelecek yıl gelir elde edemeyeceği tahmin ediliyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CMPS 3 yıl içinde kârsız olması bekleniyor.


Büyüyen şirketleri keşfedin